Aug 2026· International Journal of Sciences and Innovation Engineering· Vol 3, pp. 39-42· 0 citations
TL;DR
Experimental results demonstrate that the proposed system can effectively assist in the early screening of liver disease, offering a low-cost, accessible, and user-friendly diagnostic aid that bridges the gap between patients and healthcare providers.
Abstract
Abstract— Liver disease is a major cause of illness and death worldwide, and early diagnosis remains a challenge due to the limited availability of trained medical professionals for interpreting diagnostic tests. This paper presents a deep-learning-based approach for the prediction of liver disease using the Indian Liver Patient Dataset (ILPD), obtained from Kaggle and the UCI Machine Learning Repository, consisting of 583 patient records. Nine clinical attributes — age, sex, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, albumin, total protein, albumin/globulin ratio, and alkaline phosphatase — were used to train and evaluate several classification models, namely Logistic Regression, Random Forest, and an Artificial Neural Network (ANN). The dataset was preprocessed to remove missing and duplicate values, encode categorical attributes, and normalize numerical features before being split into training (80%) and testing (20%) subsets. Feature-importance analysis identified ALT as the most influential predictor of liver disease and alkaline phosphatase as the least significant. The trained model was deployed through a Flask-based web application that allows users to input clinical parameters and receive an instant prediction. Experimental results demonstrate that the proposed system can effectively assist in the early screening of liver disease, offering a low-cost, accessible, and user-friendly diagnostic aid that bridges the gap between patients and healthcare providers.
The results show how a combination of explainable ML and accessible clinical biomarkers can offer a precise, transparent, and clinically interpretable framework for early CKD diagnosis, risk stratification, and informed clinical decision making.
M. Khuntia, Hariballav Mahapatra, N. Lodha· Kidneys· 0 citations
The findings support the feasibility of leveraging large-scale inpatient laboratory data for risk-stratification model development and show good discrimination and interpretability for liver cancer prediction in a hospitalized real-world cohort using routinely available clinical and laboratory data.
Ce-Xiong Fu, Fang Li, Shi-Bing Li et al.· Frontiers in Cell and Develo...· 0 citations
BACKGROUND
Machine learning (ML) and deep learning (DL) models are increasingly applied to cardiovascular risk prediction, yet their comparative performance in small tabular clinical datasets remains uncertain. This study compared conventional machine learning models and a deep neural network for predicting angiographi...
Erfan Barootchi, Pardis Zamani, R. Birgani et al.· American Journal of Cardiova...· 0 citations
Cardiovascular diseases (CVDs) are still the leading cause of death in the world and are responsible for killing about 17.9 million people every year. Identification of high-risk individuals is a key factor in lowering the death rate, but this is difficult because cardiac risk is multifactorial and nonlinear. Using a d...
Shreya V. Bhatt, K. Agarwal, Naveen Kandwal· International Workshop on Ar...· 0 citations
This work provides an intelligent and comprehensible method of predicting CKD using ML and ensemble methods and identifies six clinically significant items, including haemoglobin, serum creatinine, albumin, high blood pressure, age, and diabetes mellitus.
The main objective of this study is to develop an interpretable soft-computing model that can classify patients as having liver disease or not and the results demonstrate that the proposed approach is highly accurate and suitable for real-world liver disease detection.
Pranabes Gangopadhyay, Tirtharaj Sen, Bidesh Chakraborty et al.· Discover Applied Sciences· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.